Inventor · disambiguated record
Anne Mengel
Also filed as: MENGEL ANNE
27 granted patents·27 pending applications·63 citations·filing 2004–2023
94Inventor score
Top patents by PatentIndex Score
54 records- 0190US11891404B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2022·Granted Feb 6, 2024·1 cites·10 claims
- 0288US12152041B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2022·Granted Nov 26, 2024·1 cites·6 claims
- 0387US11440923B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2018·Granted Sep 13, 2022·3 cites·15 claims
- 0486US11478451B1Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Oct 25, 2022·3 cites·16 claims
- 0586US11401278B2Macrocyclic indole derivativesBROAD INST INC·Filed 2018·Granted Aug 2, 2022·3 cites·13 claims
- 0685US11447504B2Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Sep 20, 2022·3 cites·14 claims
- 0785US11286263B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2018·Granted Mar 29, 2022·3 cites·9 claims
- 0881US7825128B2Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugsBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 2, 2010·7 cites·18 claims
- 0978US10266548B2Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2017·Granted Apr 23, 2019·2 cites·2 claims
- 1078US9643953B2Substituted benzylpyrazolesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·5 cites·10 claims
- 1177US9682974B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Jun 20, 2017·4 cites·8 claims
- 1277US7442794B2Rearranged pentanols, a process for their production and their use as anti-inflammatory agentsSCHERING AG·Filed 2004·Granted Oct 28, 2008·11 cites·10 claims
- 1375US9745285B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·3 cites·5 claims
- 1474US12227501B23-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitorsBAYER AG·Filed 2020·Granted Feb 18, 2025·1 cites·15 claims
- 1574US9765058B2Substituted benzylpyrazolesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·3 cites·14 claims
- 1671US8642611B2Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2008·Granted Feb 4, 2014·2 cites·15 claims
- 1769US7863283B2Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicamentsBAYER SCHERING PHARMA AG·Filed 2008·Granted Jan 4, 2011·1 cites·23 claims
- 1866US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 1966US9655887B2Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraceptionBayer Pharma AG·Filed 2014·Granted May 23, 2017·1 cites·19 claims
- 2066US7659297B2Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsBAYER SCHERING PHARMA AG·Filed 2004·Granted Feb 9, 2010·3 cites·12 claims
- 2165US8097627B2Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsREHWINKEL HARTMUT·Filed 2009·Granted Jan 17, 2012·0 cites·18 claims
- 2264US10604532B2Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2019·Granted Mar 31, 2020·0 cites·6 claims
- 2361US2016046604A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2459US2008153859A1Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsREHWINKEL HARTMUT·Filed 2008·Application pending·0 cites
- 2558US7662821B2Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsBAYER SCHERING PHARMA AG·Filed 2004·Granted Feb 16, 2010·1 cites·15 claims
- 2658US7638515B2Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsBAYER SCHERING PHARMA AG·Filed 2004·Granted Dec 29, 2009·1 cites·26 claims
- 2754US2025188075A1Substituted heterocyclic csnk1 inhibitorsBROAD INST INC·Filed 2023·Application pending·0 cites
- 2853US2017275267A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2952US2014249133A1Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 3051US2016046610A13-heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3149US12338250B2Methods of preparing macrocyclic indolesBROAD INST INC·Filed 2020·Granted Jun 24, 2025·0 cites·20 claims
- 3249US2023365554A1Substituted pyrrolo-pyridinone derivatives and therapeutic uses thereofBROAD INST INC·Filed 2021·Application pending·0 cites
- 3348US2015141372A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3448US2023322767A1Aryl substituted pyrrolo-pyridinones and therapeutic uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 3547US2023391769A1Substituted heterocyclic compounds and therapeutic uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 3646US2006229305A1Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsBERGER MARKUS·Filed 2006·Application pending·0 cites
- 3745US2007015761A1Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsMENGEL ANNE·Filed 2006·Application pending·0 cites
- 3845US2017275268A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 3944US2016145267A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4044US2008004268A1Inhibitors of soluble adenylate cyclaseNGUYEN DUY·Filed 2007·Application pending·0 cites
- 4144US2016168130A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4243US2006074084A1Inhibitors of soluble adenylate cyclaseNGUYEN DUY·Filed 2005·Application pending·0 cites
- 4343US2021253598A1Aryl annulated macrocyclic indole derivativesBAYER AG·Filed 2018·Application pending·0 cites
- 4442US2005090559A1Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agentsFiled 2004·Application pending·0 cites
- 4542US2005222154A1Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsREHWINKEL HARTMUT·Filed 2004·Application pending·0 cites
- 4642US2016151370A1Substituted BenzylpyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4742US2006167025A1Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugsBERGER MARKUS·Filed 2005·Application pending·0 cites
- 4841US9062041B22H-indazoles as EP2 receptor antagonistsBAYER IP GMBH·Filed 2012·Granted Jun 23, 2015·0 cites·9 claims
- 4940US10894784B2Heteroarylbenzimidazole compoundsBayer Pharma AG·Filed 2016·Granted Jan 19, 2021·0 cites·15 claims
- 5040US2007015750A1Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agentsBAEURLE STEFAN·Filed 2006·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anne Mengel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →